CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)	9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ (1,614,572)	$ 1,181,427
Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities -
Depreciation and Amortization	15,785	18,225
Gain on Sale of Patents		(2,276,286)
Gain on Sale of Assets	(4,599)	(9,457)
Gain on Settlement of Accounts Payable	(76,149)
Stock-based Compensation Expense	73,913	52,160
Non-cash Provision for Settlement of Claims for Liquidated Damages	629,000
Non-cash Interest Expense	1,250	28,958
Changes in Operating Assets and Liabilities -
Accounts Receivable, net	58,826	29,345
Inventories	(160,375)	(32,065)
Prepaid Expenses	(38,536)	(755)
Accounts Payable	37,669	(414,614)
Customer Advances	(3,087)	(13,673)
Accrued Expenses	23,668	123,466
Net Cash Used In Operating Activities	(1,057,207)	(1,313,269)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net Proceeds from Sale of Patents		2,463,171
Purchases of Property and Equipment	(3,550)
Additional Patent Costs		(1,724)
Proceeds from Sale of Assets	4,599	9,457
Net Cash Provided By Investing Activities	1,049	2,470,904
CASH FLOWS FROM FINANCING ACTIVITIES:
Gross Proceeds from September 2012 Private Placement of Common Stock and Warrants	2,500,015
Private Placement Expenses Incurred and Paid as of March 31, 2013	(308,896)
Proceeds From Exercise of Warrants to Purchase Common Stock (50,000 Shares)	50,000
Payment of Principal and Interest on 10% Senior Convertible Notes	(52,500)	(740,972)
Net Cash Provided by (Used In) Financing Activities	2,188,619	(740,972)
NET INCREASE IN CASH AND CASH EQUIVALENTS	1,132,461	416,663
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	145,923	19,556
CASH AND CASH EQUIVALENTS, END OF PERIOD	1,278,384	436,219
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash Paid for Income Taxes	912	912
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Issuance of Common Stock and Warrants for Settlement of Claims for Liquidated Damages (370,000 shares and 370,000 warrants)	629,000
Issuance of Common Stock to Satisfy Deferred Compensation Obligations (245,326 shares)		$ 674,645